NCT02547493 - Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2016

Primary Completion Date

January 18, 2021

Study Completion Date

January 18, 2021

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

pneumococcal polysaccharide vaccine

Vaccination with PPSV on first day. NB : PPSV vaccine Pneumo23 has been replaced in September 2017 by the equivalent vaccine Pneumovax because of the stop of commercialization of Pneumo23 in France by the pharmaceutical company.

BIOLOGICAL

pneumococcal conjugate vaccine

Patients are vaccinated with Prevenar13 on the first day, and with Pneumo23/Pneumovax two months later.

DRUG

Abatacept

Abatacept started on frst day

Trial Locations (11)

30029

CHU Carémeau, Nîmes

33076

CHU Pellegrin, Bordeaux

34295

CHRU de Montpellier, Montpellier

45000

CHU Orléans, Orléans

59037

CHRU Roger Salengro, Lille

63000

CHU Montpied, Clermont-Ferrand

67200

CHU Hautepierre, Strasbourg

78013

CHU La pitié salpétriere, Paris

80054

CHU Nord, Amiens

94275

CHU Bicêtre, Le Kremlin-Bicêtre

98012

CHPG Monaco, Monaco